A novel view of the adult bone marrow stem cell hierarchy and stem cell trafficking

Leukemia

Volumn 29, Issue 4, 2015, Pages 776-782

  Ratajczak, M Z ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CHEMOATTRACTANT; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; COMPLEMENT; HEME OXYGENASE 1; METFORMIN; NORADRENALIN UPTAKE INHIBITOR; PLERIXAFOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STROMAL CELL DERIVED FACTOR 1; CXCL12 PROTEIN, HUMAN;

ADULT STEM CELL; BLOOD; BONE MARROW; CARCINOGENESIS; CELL HOMING; CELL HYPOXIA; CELL MIGRATION; CELL STRUCTURE; CELL SURFACE; CORD BLOOD STEM CELL TRANSPLANTATION; ECTODERM; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENGRAFTMENT; HEMANGIOBLAST; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOTHESIS; NONHUMAN; PLURIPOTENT STEM CELL; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL MOBILIZATION; STEM CELL NICHE; STEM CELL TRANSPLANTATION; YOLK SAC; ADULT; BONE MARROW CELL; CELL LINEAGE; CELL MOTION; CLASSIFICATION; CYTOLOGY; GENE EXPRESSION; GENETICS; GERM CELL; IMMUNOLOGY; METABOLISM;

ADULT; BONE MARROW; BONE MARROW CELLS; CELL LINEAGE; CELL MOVEMENT; CHEMOKINE CXCL12; COMPLEMENT SYSTEM PROTEINS; GENE EXPRESSION; GERM CELLS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 84926445768     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.346     Document Type: Review

References (86)

1. Landsteiner K. Individual differences in human blood. Science 1931; 73: 403-409.
2. Ramalho-Santos M, Willenbring H. On the origin of the term ?stem cell'. Cell Stem Cell 2007; 1: 35-38.
3. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 1961; 14: 213-222.
4. Thomas ED. Bone marrow transplantation from the personal viewpoint. Int J Hematol 2005; 81: 89-93.
5. Snell GD. The Nobel Lectures in Immunology. Lecture for the Nobel Prize for Physiology or Medicine, 1980: Studies in histocompatibility. Scand J Immunol 1992; 36: 513-526.
6. Hénon P. New developments in peripheral blood stem cell transplants. Leukemia 1992; 6: 106-109.
7. Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: The first 25 years and beyond. Blood 2013; 122: 491-498.
8. Ratajczak MZ, Jadczyk T, P?dziwiatr D, Wojakowski W. New advances in stem cell research: Practical implications for regenerative medicine. Pol Arch Med Wewn 2014; 124: 417-426.
9. Cunningham JJ, Ulbright TM, Pera MF, Looijenga LH. Lessons from human teratomas to guide development of safe stem cell therapies. Nat Biotechnol 2012; 30: 849-857.
10. Mertelsmann R. Plasticity of bone marrow-derived stem cells. J Hematother Stem Cell Res 2000; 9: 957-960.
11. Majka M, Janowska-Wieczorek A, Ratajczak J, Ehrenman K, Pietrzkowski Z, Kowalska MA et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001; 97: 3075-3085.
12. Ratajczak MZ, Kucia M, Jadczyk T, Greco NJ, Wojakowski W, Tendera M et al. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: Can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia 2012; 26: 1166-1173.
13. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: Evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006; 20: 847-856.
14. Kucia M, Reca R, Campbell FR, Zuba-Surma E, Majka M, Ratajczak J et al. A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia 2006; 20: 857-869.
15. Kucia M, Halasa M, Wysoczynski M, Baskiewicz-Masiuk M, Moldenhawer S, Zuba-Surma E et al. Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: Preliminary report. Leukemia 2007; 21: 297-303.
16. Ratajczak MZ, Zuba-Surma E, Wojakowski W, Suszynska M, Mierzejewska K, Liu R et al. Very small embryonic-like stem cells (VSELs) represent a real challenge in stem cell biology: Recent pros and cons in the midst of a lively debate. Leukemia 2014; 28: 473-484.
17. Galloway JL, Zon LI. Ontogeny of hematopoiesis: Examining the emergence of hematopoietic cells in the vertebrate embryo. Curr Top Dev Biol 2003; 53: 139-158.
18. Saitou M. Germ cell specification in mice. Genet Dev 2009; 19: 386-395.
19. Palis J. Primitive and definitive erythropoiesis in mammals. Front Physiol 2014; 5: 3-9.
20. Adamo L, Naveiras O, Wenzel PL, McKinney-Freeman S, Mack PJ, Gracia-Sancho J et al. Biomechanical forces promote embryonic haematopoiesis. Nature 2009; 459: 1131-1135.
21. Lux CT, Yoshimoto M, McGrath K, Conway SJ, Palis J, Yoder MC. All primitive and definitive hematopoietic progenitor cells emerging before E10 in the mouse embryo are products of the yolk sac. Blood 2008; 111: 3435-3438.
22. De Miguel MP, Arnalich Montiel F, Lopez Iglesias P, Blazquez Martinez A, Nistal M. Epiblast-derived stem cells in embryonic and adult tissues. Int J Dev Biol 2009; 53: 1529-1540.
23. Woodruff K, Wang N, May W, Adrone E, Denny C, Feig SA. The clonal nature of mediastinal germ cell tumors and acute myelogenous leukemia. A case report and review of the literatur. Cancer Genet Cytogenet 1995; 79: 25-31.
24. Chaganti RS, Ladanyi M, Samaniego F, Offit K, Reuter VE, Jhanwar SC et al. Leukemic differentiation of a mediastinal germ cell tumor. Genes Chromosomes Cancer 1989; 1: 83-87.
25. Nichols CR, Hoffman R, Einhorn LH, Williams SD, Wheeler LA, Garnick MB. Hematologic malignancies associated with primary mediastinal germ-cell tumors. Ann Int Med 1985; 102: 603-609.
26. Nakada D, Oguro H, Levi BP, Ryan N, Kitano A, Saitoh Y et al. Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancy. Nature 2014; 505: 555-558.
27. Selleri C, Catalano L, De Rosa G, Fontana R, Notaro R, Rotoli B. Danazol: In vitro effects on human hemopoiesis and in vivo activity in hypoplastic and myelodysplastic disorders. Eur J Haematol 1991; 47: 197-203.
28. Suszynska M, Poniewierska-Baran A, Gunjal P, Ratajczak J, Marycz K, Kakar SS et al. Expression of the erythropoietin receptor by germline-derived cells-further support for a potential developmental link between the germline and hematopoiesis. J Ovarian Res 2014; 7: 66.
29. Rich IN. Primordial germ cells are capable of producing cells of the hematopoietic system in vitro. Blood 1995; 86: 463-472.
30. Ohtaka T, Matsui Y, Obinata M. Hematopoietic development of primordial germ cell-derived mouse embryonic germ cells in culture. Biochem Biophys Res Com 1999; 260: 475-482.
31. Yang J, Liao W, Ma Y. Role of SALL4 in hematopoiesis. Curr Opin Hematol 2012; 19: 287-291.
32. Nayernia K, Lee JH, Drusenheimer N, Nolte J, Wulf G, Dressel R et al. Derivation of male germ cells from bone marrow stem cells. Lab Invest 2006; 86: 654-663.
33. Lue Y, Erkkila K, Liu PY, Ma K, Wang Ch, Hikim AS et al. Fate of bone marrow stem cells transplanted into the testis. Am J Pathol 2007; 170: 899-908.
34. Vacanti MP, Roy A, Cortiella J, Bonassar L, Vacanti CA. Identification and initial characterization of spore-like cells in adult mammals. J Cell Biochem 2001; 80: 455-460.
35. Beltrami AP, Cesselli D, Bergamin N, Marcon P, Rigo S, Puppato E et al. Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood 2007; 110: 3438-3446.
36. Wakao S, Kitada M, Kuroda Y, Shigemoto T, Matsuse D, Akashi H et al. Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci USA 2011; 108: 9875-9880.
37. Jiang Y, Vaessen B, Lenvik T, Blackstad M, Reyes M, Verfaillie CM. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 2002; 30: 896-904.
38. Kögler G, Sensken S, Airey JA, Trapp T, Müschen M, Feldhahn N et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004; 200: 123-135.
39. D'Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 2004; 117: 2971-2981.
40. Shin DM, Liu R, Klich I, Wu W, Ratajczak J, Kucia M et al. Molecular signature of adult bone marrow-purified very small embryonic-like stem cells supports their developmental epiblast/germ line origin. Leukemia 2010; 24: 1450-1461.
41. Kassmer SH, Jin H, Zhang PX, Bruscia EM, Heydari K, Lee JH et al. Very small embryonic-like stem cells from the murine bone marrow differentiate into epithelial cells of the lung. Stem Cells 2013; 31: 2759-2766.
42. Havens AM, Sun H, Shiozawa Y, Jung Y, Wang J, Mishra A et al. Human and murine very small embryonic-like cells represent multipotent tissue progenitors, in vitro and in vivo. Stem Cells Dev 2014; 23: 689-701.
43. Virant-Klun I, Zech N, Rozman P, Vogler A, Cvjeticanin B, Klemenc P et al. Putative stem cells with an embryonic character isolated from the ovarian surface epithelium of women with no naturally present follicles and oocytes. Differentiation 2008; 76: 843-856.
44. Bhartiya D, Kasiviswananthan S, Shaikh A. Cellular origin of testis-derived pluripotent stem cells: A case for very small embryonic-like stem cells. Stem Cells Dev 2012; 21: 670-674.
45. Ratajczak J, Zuba-Surma E, Klich I, Liu R, Wysoczynski M, Greco N et al. Hematopoietic differentiation of umbilical cord blood-derived very small embryonic/epiblast-like stem cells. Leukemia 2011; 25: 1278-1285.
46. Shin DM, Zuba-Surma EK, Wu W, Ratajczak J, Wysoczynski M, Ratajczak MZ et al. Novel epigenetic mechanisms that control pluripotency and quiescence of adult bone marrow-derived Oct4(+) very small embryonic-like stem cells. Leukemia 2009; 23: 2042-2051.
47. Ratajczak MZ, Shin DM, Schneider G, Ratajczak J, Kucia M. Parental imprinting regulates insulin-like growth factor signaling: A Rosetta Stone for understanding the biology of pluripotent stem cells, aging and cancerogenesis. Leukemia 2013; 27: 773-779.
48. Kucia M, Masternak M, Liu R, Shin DM, Ratajczak J, Mierzejewska K et al. The negative effect of prolonged somatotrophic/insulin signaling on an adult bone marrow-residing population of pluripotent very small embryonic-like stem cells (VSELs). Age (Dordr) 2013; 35: 315-330.
49. S?uczanowska-Gbowska S, Laszczy?ska M, Piotrowska K, Gbowski W, Rumianowski B, Masternak M et al. The effect of calorie restriction on the presence of apoptotic ovarian cells in normal wild type mice and low-plasma-IGF-1 Laron dwarf mice. J Ovarian Res 2013; 6: 67.
50. Grymula K, Piotrowska K, S?uczanowska-Gbowska S, Mierzejewska K, Tarnowski M, Tkacz M , et al. Positive effects of prolonged caloric restriction on the population of very small embryonic-like stem cells-hematopoietic and ovarian implications. J Ovarian Res 2014; 7: 68.
51. Bonig H, Papayannopoulou T. Hematopoietic stem cell mobilization: Updated conceptual renditions. Leukemia 2013; 27: 24-31.
52. Massberg S, Schaerli P, Knezevic-Maramica I, Köllnberger M, Tubo N, Moseman EA et al. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 2007; 131: 994-1008.
53. Wojakowski W, Landmesser U, Bachowski R, Jadczyk T, Tendera M. Mobilization of stem and progenitor cells in cardiovascular diseases. Leukemia 2012; 26: 23-33.
54. Borlongan CV. Bone marrow stem cell mobilization in stroke: A ?bonehead' may be good after all!. Leukemia 2011; 25: 1674-1686.
55. Dar A, Schajnovitz A, Lapid K, Kalinkovich A, Itkin T, Ludin A et al. Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells. Leukemia 2011; 25: 1286-1296.
56. Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, Thomas SA et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006; 124: 407-421.
57. Lucas D, Bruns I, Battista M, Mendez-Ferrer S, Magnon C, Kunisaki Y et al. Norepinephrine reuptake inhibition promotes mobilization in mice: Potential impact to rescue low stem cell yields. Blood 2012; 119: 3962-3965.
58. Ratajczak MZ, Kim CH, Wojakowski W, Janowska-Wieczorek A, Kucia M, Ratajczak J. Innate immunity as orchestrator of stem cell mobilization. Leukemia 2010; 24: 1667-1675.
59. Greenbaum AM, Link DC. Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization. Leukemia 2011; 25: 211-217.
60. Rettig MP, Ansstas G, DiPersio JF. Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4. Leukemia 2012; 26: 34-53.
61. Borkowska S, Suszynska M, Mierzejewska K, Ismail A, Budkowska M, Salata D et al. Novel evidence that crosstalk between the complement, coagulation and fibrinolysis proteolytic cascades is involved in mobilization of hematopoietic stem/progenitor cells (HSPCs). Leukemia 2014; 28: 2148-2154.
62. Amara U, Flierl MA, Rittirsch D, Klos A, Chen H, Acker B et al. Molecular intercommunication between the complement and coagulation systems. J Immunol 2010; 185: 5628-5636.
63. Reis ES, Lange T, Köhl G, Herrmann A, Tschulakow AV, Naujoks J et al. Sleep and circadian rhythm regulate circulating complement factors and immunoregulatory properties of C5a. Brain Behav Immun 2011; 25: 1416-1426.
64. Lévesque JP, Helwani FM, Winkler IG. The endosteal 'osteoblastic' niche and its role in hematopoietic stem cell homing and mobilization. Leukemia 2010; 24: 1979-1992.
65. Wysoczynski M, Kucia M, Ratajczak J, Ratajczak MZ. Cleavage fragments of the third complement component (C3) enhance stromal derived factor-1 (SDF-1)-mediated platelet production during reactive postbleeding thrombocytosis. Leukemia 2007; 21: 973-982.
66. Wysoczynski M, Reca R, Ratajczak J, Kucia M, Shirvaikar N, Honczarenko M et al. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood 2005; 105: 40-48.
67. Guan JL. Cell biology. Integrins, rafts, Rac, and Rho. Science 2004; 303: 773-774.
68. Lapidot T, Kollet O. The brain-bone-blood triad: Traffic lights for stem-cell homing and mobilization. Hematol Am Soc Hematol Educ Program 2010; 2010: 1-6.
69. Borkowska S, Poniewierska-Baran A, Schneider G, Suszynska M, Ratajczak J, Kucia, et al. Novel evidence that, in addition to proteolytic enzymes, lipolytic enzymes are involved in mobilization of hematopoietic stem/progenitor cells (HSPCs)-an important pro-mobilizing role identified for hematopoietic-specific phospholipase C (PLC?2). Blood 2014; 21: 2448.
70. Ratajczak MZ, Lee H, Wysoczynski M, Wan W, Marlicz W, Laughlin MJ et al. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. Leukemia 2010; 24: 976-985.
71. Golan K, Vagima Y, Ludin A, Itkin T, Cohen-Gur S, Kalinkovich A et al. S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release. Blood 2012; 119: 2478-2488.
72. Juarez JG, Harun N, Thien M, Welschinger R, Baraz R, Pena AD et al. Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice. Blood 2012; 119: 707-716.
73. Kozuka T, Ishimaru F, Fujii K, Masuda K, Kaneda K, Imai T et al. Plasma stromal cell-derived factor-1 during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Bone Marrow Transplant 2003; 31: 651-654.
74. Cecyn KZ, Schimieguel DM, Kimura EY, Yamamoto M, Oliveira JS. Plasma levels of FL and SDF-1 and expression of FLT-3 and CXCR4 on CD34+ cells assessed pre and post hematopoietic stem cell mobilization in patients with hematologic malignancies and in healthy donors. Transfus Apher Sci 2009; 40: 159-167.
75. Lee HM, Wu W, Wysoczynski M, Liu R, Zuba-Surma EK, Kucia M et al. Impaired mobilization of hematopoietic stem/progenitor cells in C5-deficient mice supports the pivotal involvement of innate immunity in this process and reveals novel promobilization effects of granulocytes. Leukemia 2009; 23: 2052-2062.
76. Wysoczynski M, Ratajczak J, Pedziwiatr D, Rokosh G, Bolli R, Ratajczak MZ. Identification of heme oxygenase 1 (HO-1) as a novel negative regulator of mobilization of hematopoietic stem/progenitor cells. Stem Cell Rev 2014; e-pub ahead of print; doi:10.1007/s12015-014-9547-7
77. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005; 106: 1901-1910.
78. Ma Q, Jones D, Springer T.A. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 1999; 10: 463-471.
79. Christopherson KW II, Hangoc G, Mantel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004; 305: 1000-1003.
80. Onai N, Zhang Yy, Yoneyama H, Kitamura T, Ishikawa S, Matsushima K. Impairment of lymphopoiesis and myelopoiesis in mice reconstituted with bone marrow-hematopoietic progenitor cells expressing SDF-1-intrakine. Blood 2000; 96: 2074-2080.
81. Ratajczak MZ, Kim CH, Abdel-Latif A, Schneider G, Kucia M, Morris AJ et al. A novel perspective on stem cell homing and mobilization: Review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients. Leukemia 2012; 26: 63-72.
82. Rossi L, Manfredini R, Bertolini F, Ferrari D, Fogli M, Zini R et al. The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration. Blood 2007; 109: 533-542.
83. Wysoczynski M, Reca R, Lee H, Wu W, Ratajczak J, Ratajczak MZ. Defective engraftment of C3aR ?/? hematopoietic stem progenitor cells shows a novel role of the C3a-C3aR axis in bone marrow homing. Leukemia 2009; 23: 1455-1461.
84. Wu W, Kim CH, Liu R, Kucia M, Marlicz W, Greco N et al. The bone marrowexpressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantation. Leukemia 2012; 26: 736-745.
85. Hoggatt J, Pelus LM. Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking. Leukemia 2010; 24: 1993-2002.
86. Avigdor A, Goichberg P, Shivtiel S, Dar A, Peled A, Samira S et al. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood 2004; 103: 2981-2989.